Skip to main content

Investors

Press releases

Ortivus initiates customer delivery projects in the Baltics
Ortivus has purchased the rights to the vehicle control system FleetCtrl from the company mpDEV via an asset purchase agreement. FleetCtrl will be an integrated part of MobiMed but can also be used as a stand-alone solution for all types of blue light...
We are pleased to announce that Ortivus’ tender application for MobiMed Life has been approved by the NHS Supply Chain and that the company thereby has been selected for participation in the NHS Framework Agreement to provide External Defibrillation...
The Stockholm County Healthcare District (SLSO) has approved Ortivus as a supplier of MobiMed Life, semi-automatic defibrillators, and the company has thereby qualified to become a part of the region’s framework agreement. Ortivus' solutions meet all...
As previously reported, Estonian Health Insurance Fund Haigekassa decided to award Ortivus and Telia Eesti, a contract on the delivery of MobiMed ePR to Estonia’s entire ambulance fleet. The contract, with an order value of approximately 26 MSEK, has...
We are pleased to announce that Ortivus’ tender application for MobiMed ePR has been approved by the East of England NHS Collaborative Procurement Hub and has thereby qualified to be a part of the East of England Framework tender. This is an important...
2023-02-17 08:30 Ortivus' Year-end Report, January - December 2022 Regulatory Interim
Ortivus ends 2022 with a growth of 10% for the full year
As previously reported, Ortivus AB signed a Letter of Intent in December 2022 with technology company H&E Solutions AB regarding the acquisition of about 10% of the company's shares. The contract is now signed, and the acquisition has been completed...
We are very pleased to announce that the Estonian Health Insurance Fund Haigekassa has decided to award Telia Eesti, with Ortivus as a subcontractor, a contract on the delivery of MobiMed ePR to Estonia’s entire ambulance fleet. Estonia is a new customer...
Ortivus AB has signed a Letter of Intent with the technology company H&E Solutions AB. Ortivus intends to complete an acquisition of 10% of the company’s shares during January 2023.

Get in touch

Empower your team with smarter tools

Discover why leading healthcare organisations are choosing Ortivus.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required